Registered entities
Ariceum Therapeutics Gmbh
Reg. No. D2601_HRB276039Germany
Ariceum Therapeutics GmbH
Reg. No. HRB276039Germany
Innovation
6 patent families (3 granted) — focus: Human necessities; filing pace accelerating. Cited 92 times.
| Year | Filings |
|---|---|
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 6 |
| 2026 | 1 |
Social engagement
Social engagement: 5.8K social following, 7 posts in the last 12 months — below the industry typical range.
Investor mix
6 investors on record; lead investors include Healthcap, Andera Partners, Earlybird.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 50% |
| Private equity | 2 | 33% |
| Other / undisclosed | 1 | 17% |
Recent activity
24 Nov 2025
Event
12th Annual Brisbane Cancer Conference
12 Nov 2025
Partnership
Ariceum Global Radiopharma Inc.
11 Nov 2025
Milestone
regulatory